Small Molecules

Business & Regulation Business Practice

12/06/2023 | Marijn Verhoef, Martijn van Gerven | 5 min read

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

Business & Regulation Standards & Regulation

12/01/2023 | Rob Coker | 3 min read

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Discovery & Development Ingredients

11/02/2023 | Stephanie Vine | 4 min read

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Discovery & Development Drug Discovery

10/25/2023 | 5 min read

Why small molecule microarrays are leading the way in small molecule drug discovery

Discovery & Development Drug Discovery

10/04/2023 | Stephanie Vine | 7 min read

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

Discovery & Development Drug Discovery

09/18/2023 | 3 min read

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

Discovery & Development Drug Discovery

09/14/2023 | 6 min read

Sitting Down With… Sharon L Rogers, AmyriAD CEO, Renowned drug developer, 2023 Power Lister, and Olympic figure skating official

Manufacture Small Molecules

09/05/2023 | Jim Gastle, Grant Peters | 4 min read

US-based law and patenting experts offer their thoughts on IP protection in the digital age

Manufacture Packaging

08/24/2023 | Jared O’Connell | 3 min read

What sustainability benefits can be gained from smart choices and reduced material use?

Discovery & Development Drug Delivery

08/24/2023 | Paul Rennie | 5 min read

We need non-opioid options for pain relief. Paradigm Biopharmaceuticals discuss their studies into a new option for osteoarthritis patients